These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 7117512)
1. QSAR in a series of muscarinic agents. Note IV. - New pyridine and furan derivatives. Pratesi P; Villa L; Ferri V; De Micheli C; Grana E; Santagostino Barbone MG; Silipo C; Vittoria A Farmaco Sci; 1982 Jun; 37(6):398-410. PubMed ID: 7117512 [TBL] [Abstract][Full Text] [Related]
2. QSAR in a series of muscarinic agents. Note II - Pyridine and furan derivatives. Pratesi P; Villa L; Ferri V; de Micheli C; Grana E; Santagostino Barbone MG; Grieco C; Silipo C; Vittoria A Farmaco Sci; 1980 Aug; 35(8):621-35. PubMed ID: 7450050 [TBL] [Abstract][Full Text] [Related]
3. QSAR in a series of muscarinic agents. Note V. New sets of rigid and flexible ligands. Pratesi P; Villa L; Ferri V; De Micheli C; De Amici M; Grana E; Santagostino Barbone MG; Silipo C; Vittoria A; Cappello B Farmaco Sci; 1984 Mar; 39(3):171-88. PubMed ID: 6714413 [TBL] [Abstract][Full Text] [Related]
4. OSAR in a series of muscarinic agents. Note III--Alkyltrimethylammonium salts, ethers and esters of choline. Pratesi P; Villa L; Ferri V; De Micheli C; Grana E; Santagostino Barbone MG; Silipo C; Vittoria A Farmaco Sci; 1981 Sep; 36(9):749-64. PubMed ID: 7297670 [TBL] [Abstract][Full Text] [Related]
5. QSAR in a series of muscarinic agents. Note VI. Five-membered cyclic ligands. Pratesi P; Grana E; Santagostino Barbone MG; La Rotonda MI; Silipo C; Vittoria A Farmaco Sci; 1986 May; 41(5):336-45. PubMed ID: 3720943 [TBL] [Abstract][Full Text] [Related]
6. Novel functional M1 selective muscarinic agonists. 2. Synthesis and structure-activity relationships of 3-pyrazinyl-1,2,5,6-tetrahydro-1-methylpyridines. Construction of a molecular model for the M1 pharmacophore. Ward JS; Merritt L; Klimkowski VJ; Lamb ML; Mitch CH; Bymaster FP; Sawyer B; Shannon HE; Olesen PH; Honoré T J Med Chem; 1992 Oct; 35(22):4011-9. PubMed ID: 1433209 [TBL] [Abstract][Full Text] [Related]
7. Muscarinic cholinergic agonists and antagonists of the 3-(3-alkyl-1,2,4-oxadiazol-5-yl)-1,2,5,6-tetrahydropyridine type. Synthesis and structure-activity relationships. Sauerberg P; Kindtler JW; Nielsen L; Sheardown MJ; Honoré T J Med Chem; 1991 Feb; 34(2):687-92. PubMed ID: 1995893 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of some carbocyclic analogs of muscarine. Sundelin KG; Wiley RA; Givens RS; Rademacher DR J Med Chem; 1973 Mar; 16(3):235-9. PubMed ID: 4733104 [No Abstract] [Full Text] [Related]
10. Cholinergic compounds. 9. Cyclohexane analogues of deoxamuscarine and derivatives. Angeli P; Melchiorre C; Giannella M; Pigini M; Cingolani ML J Med Chem; 1977 Mar; 20(3):398-400. PubMed ID: 845872 [No Abstract] [Full Text] [Related]
11. Cholinergic agents structurally related to furtrethonium. 2. Synthesis and antimuscarinic activity of a series of N-[5-[(1'-substituted-acetoxy) methyl]-2-furfuryl]dialkylamines. Feriani A; Gaviraghi G; Toson G; Mor M; Barbieri A; Grana E; Boselli C; Guarneri M; Simoni D; Manfredini S J Med Chem; 1994 Dec; 37(25):4278-87. PubMed ID: 7996539 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and pharmacological evaluation of perhydropyrrolo [3,4-c]pyridine derivatives. Altomare C; Carotti A; Casini G; Cellamare S; Ferappi M; Brigiani GS; Persichella M Farmaco; 1990 May; 45(5):489-97. PubMed ID: 1977402 [TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship studies in the field of calcium antagonists. Xanthone 1,4-dihydropyridines bearing a 2,3-lactone ring. Rampa A; Budriesi R; Bisi A; Fabbri G; Barili PL; Chiarini A; Valenti P Arzneimittelforschung; 1995 Sep; 45(9):957-62. PubMed ID: 7488312 [TBL] [Abstract][Full Text] [Related]
14. Derivatives of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide. Nilsson BM; Ringdahl B; Hacksell U J Med Chem; 1988 Mar; 31(3):577-82. PubMed ID: 3346873 [TBL] [Abstract][Full Text] [Related]
15. Relation between structure and cholinergic activity. II. Synthesis and muscarinic activity of some sulfur analogs of 2-methyl-4-trimethylammoniomethyl-1,3-dioxolane-iodide. Elferink JG; Salemink CA Arzneimittelforschung; 1975 Nov; 25(11):1702-5. PubMed ID: 1243076 [TBL] [Abstract][Full Text] [Related]
16. Stereochemical requirements for central and peripheral muscarinic and antimuscarinic activity of some acetylenic compounds related to oxotremorine. Dahlbom R; Jenden DJ; Resul B; Ringdahl B Br J Pharmacol; 1982 Jun; 76(2):299-304. PubMed ID: 7093587 [TBL] [Abstract][Full Text] [Related]
17. [Structure-activity relationship in the series of muscarinic acetylcholine receptor agonists: three types of agonist-receptor complexes]. Tropsha AE; Nizhniĭ SV; Iaguzhinskiĭ LS Bioorg Khim; 1985 Oct; 11(10):1391-401. PubMed ID: 4074399 [TBL] [Abstract][Full Text] [Related]
18. Alkylating partial muscarinic agonists related to oxotremorine. N-[4-[(2-haloethyl)methylamino]-2-butynyl]-5-methyl-2-pyrrolidones. Ringdahl B; Roch M; Katz ED; Frankland MC J Med Chem; 1989 Mar; 32(3):659-63. PubMed ID: 2918515 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and muscarinic activity of a series of tertiary and quaternary N-substituted guvacine esters structurally related to arecoline and arecaidine propargyl ester. Wolf-Pflugmann M; Lambrecht G; Wess J; Mutschler E Arzneimittelforschung; 1989 May; 39(5):539-44. PubMed ID: 2757669 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and muscarinic activity of some muscarone analogs. De Micheli C; De Amici M; Grana E; Zonta F; Giannella M; Piergentili A Farmaco; 1993 Oct; 48(10):1333-48. PubMed ID: 8117377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]